SIGNIFICANT EVENTS Significant events during the financial year are as disclosed in notes 39 and 40 to the financial statements. SUBSEQUENT EVENT Significant event subsequent to the end of the reporting period is as disclosed in note 45 to the financial statements. CONSOLIDATION OF SUBSIDIARIES WITH DIFFERENT FINANCIAL YEAR END Pursuant to Section 247(7) of the Companies Act 2016, the Company has applied and has been granted approval by the Companies Commission of Malaysia for the following subsidiaries of the Company to continue to have or to adopt a financial year which does not coincide with the Company in relation to the financial year ended 31 December 2023: • Parkway Healthcare India Private Limited • Andaman Alliance Healthcare Limited • Gleneagles Healthcare India Private Limited (formerly known as Ravindranath GE Medical Associates Private Limited) (“GHIPL”) and its subsidiaries (“GHIPL Group”) • Fortis Healthcare Limited (“Fortis”) and its subsidiaries (“Fortis Group”) The details of the subsidiaries of GHIPL and Fortis are disclosed in note 41 to the financial statements. AUDITORS The auditors, KPMG PLT have indicated their willingness to accept re-appointment. The auditors' remuneration is disclosed in note 28 to the financial statements. Signed on behalf of the Board of Directors in accordance with a resolution of the Directors: Tan Sri Mohammed Azlan Bin Hashim Director Ong Ai Lin Director Date: 29 February 2024 Annual Report 2023 131
RkJQdWJsaXNoZXIy NDgzMzc=